Testing effectiveness (Phase 2)Enrolling By InvitationNCT05805839What this trial is testingImaging in Demyelinating DiseasesWho this might be right forMultiple SclerosisInflammatory Demyelinating Disease Mayo Clinic 200
Not applicableStudy completedNCT06350903What this trial is testingSuppression With Empagliflozin as an Alternative To High-Fat Low-Carbohydrate Diet for Myocardial F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET) ImagingWho this might be right forMyocardial Suppression Matthieu Pelletier-Galarneau, MD MSc 16
Large-scale testing (Phase 3)Looking for participantsNCT05456503What this trial is testingPET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620Who this might be right forFrontotemporal Lobar DegenerationAlzheimer DiseaseCognitively Normal University of Pennsylvania 72
Not applicableUnknownNCT05803746What this trial is testingPD-L2 Targeting Nanobody Radiotracer for PET Imaging of Solid TumorWho this might be right forLung CancerColorectal Cancer Peking University Cancer Hospital & Institute 20
Not applicableStudy completedNCT05522257What this trial is testingPSMA Expression and PSMA PET Imaging in Soft Tissue Sarcomas and Urothelial Cell CarcinomasWho this might be right forSarcoma,Soft TissueUrothelial Carcinoma Leiden University Medical Center 25
Early research (Phase 1)Study completedNCT03547388What this trial is testingModerate Whole Body Hyperthermia for Patients Undergoing Re-irradiation for Head and Neck Cancer -Influence on the Tumor MicroenvironmentWho this might be right forHead and Neck NeoplasmsRecurrence Tumor Charite University, Berlin, Germany 10
Not applicableUnknownNCT05824962What this trial is testingA Non-invasive Diagnostic Model for Intestinal Fibrosis in Crohn's Disease Based on 18F-FAPI PET ImagingWho this might be right forCrohn Disease Xiao Chen 50
Testing effectiveness (Phase 2)Study completedNCT00855894What this trial is testingThe Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Genentech, Inc. 41
Not applicableStudy completedNCT05534594What this trial is testingEvaluation of the 18F-PSMA Positron Emission Tomography (PET)/CT in Patients With Medullary Thyroid CancerWho this might be right forMedullary Thyroid CancerMedullary Thyroid CarcinomaThyroid Carcinoma, Medullary+1 more University Medical Center Groningen 8
Very early researchStudy completedNCT05725070What this trial is testingPhase 0/1 Study of 212Pb-NG001 in mCRPCWho this might be right forMetastatic Castration-resistant Prostate Cancer ARTBIO Inc. 3
Not applicableStudy completedNCT04014673What this trial is testingNatural History Characterization in Symptomatic and Asymptomatic Progranuline Gene Mutation CarriersWho this might be right forFrontotemporal Lobar Degeneration Assistance Publique - Hôpitaux de Paris 78
Testing effectiveness (Phase 2)Study completedNCT02162446What this trial is testing68Ga-OPS202 Study for Diagnostic Imaging of GEP NETWho this might be right forGastroenteropancreatic Neuroendocrine Tumors Ipsen 12
Early research (Phase 1)Study completedNCT02297386What this trial is testing[18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate CancerWho this might be right forProstate CancerLocalized Prostate Cancer Memorial Sloan Kettering Cancer Center 3
Not applicableLooking for participantsNCT06089486What this trial is testingMARINER Trial: Multiparametric Cardiac PET for CAV Surveillance After Heart TransplantationWho this might be right forCardiac Allograft Vasculopathy Ottawa Heart Institute Research Corporation 576
Not applicableStudy completedNCT06555861What this trial is testingLocal Recurrence Prediction of by Texture Analysis Derived From Positron Emission Tomography (PET / CT) Imaging of Non-small Cell Lung Cancer (NSCLC) Treated With Stereotactic Radiotherapy (SBRT) (Retros MUMOFRAT)Who this might be right forIdentify FDG PET/CT Parameters Predictive of Local Control University Hospital, Brest 87
Not applicableUnknownNCT02600442What this trial is testingAssessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular MarkersWho this might be right forBreast NeoplasmsBreast Cancer Assistance Publique - Hôpitaux de Paris 168
Early research (Phase 1)Study completedNCT00838877What this trial is testingPositron Emission Tomography (PET) Study With [18F]AZD4694 and [11C]AZD2184, Candidate PET Ligands for Aβ AmyloidWho this might be right forAlzheimer's Disease AstraZeneca 26
Not applicableNot Yet RecruitingNCT07128277What this trial is testingClinical Study of Trap (FAPI) 3 PET Imaging in Noninvasive Diagnosis of Malignant TumorsWho this might be right forCancer Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 10
Not applicableLooking for participantsNCT06372444What this trial is testingMechanisms of Acute Kidney Injury in Severe InfectionsWho this might be right forSepsisAKI - Acute Kidney InjuryPositron Emission Tomography (PET) Uppsala University Hospital 15
Early research (Phase 1)Study completedNCT01565330What this trial is testingTwo Doses of 18F-AV-45 in Alzheimer's Disease and Healthy VolunteersWho this might be right forAlzheimer Disease Avid Radiopharmaceuticals 20